Monitoring Patients on IBD Therapies: How to Monitor? What Is the Im…

Cedars Sinai

C. Ha

ESMO 2024 Summary: Treatment Strategies and Sequencing in Carcinoid …

2024 ESMO Annual Meeting Insights Hub

R. Riechelmann

Hormone Control and Management of Functional NET Syndromes

North American Neuroendocrine Tumor Society

H. Assi

Practice Changing Topics - How the Experts Treat With Dr. Chandler P…

Practice Changing Topics - How the Experts Treat

C. Park, A. Chauhan

Top Ten Advances in IBD 2023

Northwestern Medicine Gastroenterology

S. Hanauer

Positioning Medical Therapy in IBD

Washington University in St. Louis

M. Ciorba

SWOG S2012: 1L Chemo +/- Atezolizumab in Advanced Extrapulmonary Neu…

Fred Hutchinson Cancer Center

D. Zhen

DDW 2023 Updates and Perspectives: Evolution in Medical Treatments f…

DDW 2023 Conference Coverage

S. Hanauer

ACAAI 2024 Insights: The Bench to Bedside Pathway to Bring a Biologi…

ACAAI 2024 Insights

T. B. Casale

Update of Anti-TNF Therapy in Crohn's Disease

Columbia University

G. Lichtenstein

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

Gil Melmed

New and Emerging Therapies for Inflammatory Bowel Disease

University of Colorado Department of Medicine

W. Ahmed

How I Optimize Biologic Therapies in IBD

Providence Swedish

T. L. Zisman

Leukocyte Trafficking Agents in the Management of IBD

Washington University in St. Louis

K. Huff-Hardy

Rethinking Current and Future Treatment Sequence of Moderate to Seve…

Columbia University

E. Scherl

Starting IBD Patients on Biologic Therapy: How Long to Wait Before D…

Neeraj Narula

Update of Anti-Integrin Therapy in IBD

Columbia University

B. Sands

Medical Therapy in IBD: Past, Present, and Future

David Choi

Hot Off the Press: What Are We Currently Using? Novel Approved IBD T…

Cedars Sinai

R. Ungaro

Update of Oral Small Molecules in IBD

Columbia University

U. Navaneethan